BIOMAT Database Logo BIOMAT Database Logo

Growth hormone and cortisol secretion after oral and intravenous administration of methyldopa. 1975

E Syvälahti, and P O Seppälä, and E Iisalo

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

E Syvälahti, and P O Seppälä, and E Iisalo
Growth hormone and cortisol secretion after oral clonidine in healthy adults.
January 1986, Psychoneuroendocrinology,
E Syvälahti, and P O Seppälä, and E Iisalo
Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
August 1975, European journal of clinical pharmacology,
E Syvälahti, and P O Seppälä, and E Iisalo
Sexual dimorphism on growth hormone secretion after oral glucose administration.
June 2012, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
E Syvälahti, and P O Seppälä, and E Iisalo
Effect of low-dose oral and intravenous dexamethasone administration on growth hormone secretion in children.
January 1997, Hormone research,
E Syvälahti, and P O Seppälä, and E Iisalo
[Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism].
January 1979, Endokrynologia Polska,
E Syvälahti, and P O Seppälä, and E Iisalo
Intravenous diazepam fails to change growth hormone and cortisol secretion in humans.
August 1986, Psychiatry research,
E Syvälahti, and P O Seppälä, and E Iisalo
Growth hormone and cortisol secretion in man.
October 1973, Acta physiologica Scandinavica,
E Syvälahti, and P O Seppälä, and E Iisalo
Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration.
March 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement,
E Syvälahti, and P O Seppälä, and E Iisalo
Dissociated patterns of nocturnal prolactin, cortisol, and growth hormone secretion after stroke.
May 1984, Neurology,
E Syvälahti, and P O Seppälä, and E Iisalo
Plasma cortisol levels in man following oral and intravenous administration of cortisol.
February 1959, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!